DK1436277T3 - Fremgangsmåde til fremstilling af 14beta-hydroxy-baccatin III-1,14-carbonat - Google Patents

Fremgangsmåde til fremstilling af 14beta-hydroxy-baccatin III-1,14-carbonat

Info

Publication number
DK1436277T3
DK1436277T3 DK02764721.3T DK02764721T DK1436277T3 DK 1436277 T3 DK1436277 T3 DK 1436277T3 DK 02764721 T DK02764721 T DK 02764721T DK 1436277 T3 DK1436277 T3 DK 1436277T3
Authority
DK
Denmark
Prior art keywords
preparation
14beta
hydroxy
carbonate
baccatin iii
Prior art date
Application number
DK02764721.3T
Other languages
English (en)
Inventor
Maria Luisa Gelmi
Donato Pocar
Ezio Bombardelli
Gabriele Fontana
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK1436277T3 publication Critical patent/DK1436277T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02764721.3T 2001-10-19 2002-07-18 Fremgangsmåde til fremstilling af 14beta-hydroxy-baccatin III-1,14-carbonat DK1436277T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI002186A ITMI20012186A1 (it) 2001-10-19 2001-10-19 Procedimento per la preparazione della 14-beta-idrossi-baccatina iii-1,14-carbonato
PCT/EP2002/008005 WO2003035633A1 (en) 2001-10-19 2002-07-18 A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate

Publications (1)

Publication Number Publication Date
DK1436277T3 true DK1436277T3 (da) 2012-01-23

Family

ID=11448529

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02764721.3T DK1436277T3 (da) 2001-10-19 2002-07-18 Fremgangsmåde til fremstilling af 14beta-hydroxy-baccatin III-1,14-carbonat

Country Status (20)

Country Link
US (1) US7078432B2 (da)
EP (1) EP1436277B1 (da)
JP (1) JP4454310B2 (da)
KR (1) KR100896542B1 (da)
CN (1) CN1271061C (da)
AT (1) ATE537160T1 (da)
AU (1) AU2002328918B2 (da)
BR (1) BR0213360B1 (da)
CA (1) CA2463915C (da)
DK (1) DK1436277T3 (da)
ES (1) ES2376162T3 (da)
HK (1) HK1069170A1 (da)
HU (1) HUP0401989A3 (da)
IL (1) IL161443A0 (da)
IT (1) ITMI20012186A1 (da)
MX (1) MXPA04003519A (da)
NO (1) NO328562B1 (da)
PL (1) PL368122A1 (da)
RU (1) RU2291866C2 (da)
WO (1) WO2003035633A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
EP2080764B1 (en) 2008-01-18 2012-08-22 INDENA S.p.A. Solid forms of ortataxel
CN103450118A (zh) * 2013-09-18 2013-12-18 江苏红豆杉药业有限公司 一种半合成法制备紫杉醇的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254517B (it) * 1992-03-06 1995-09-25 Indena Spa 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
IT1275936B1 (it) 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
FR2732341A1 (fr) * 1995-03-27 1996-10-04 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
IT1275435B (it) * 1995-05-19 1997-08-07 Indena Spa Derivati della 10-desacetil-14beta-idrossibaccatina iii,loro metodo di preparazione e formulazioni che li contengono
IT1283633B1 (it) * 1996-05-10 1998-04-23 Indena Spa Derivati tassanici loro sintesi e formulazioni che li contengono
US5811452A (en) * 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
IT1318678B1 (it) * 2000-08-10 2003-08-27 Indena Spa Procedimento per la preparazione di derivati della baccatina iii.
IT1320107B1 (it) * 2000-11-28 2003-11-18 Indena Spa Procedimento per la preparazione di derivati tassanici.
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato

Also Published As

Publication number Publication date
PL368122A1 (en) 2005-03-21
IL161443A0 (en) 2004-09-27
RU2004111669A (ru) 2005-04-20
CA2463915A1 (en) 2003-05-01
NO328562B1 (no) 2010-03-22
CN1571779A (zh) 2005-01-26
US7078432B2 (en) 2006-07-18
HUP0401989A3 (en) 2007-05-29
JP2005512977A (ja) 2005-05-12
CA2463915C (en) 2009-11-24
NO20041537L (no) 2004-04-15
EP1436277B1 (en) 2011-12-14
ATE537160T1 (de) 2011-12-15
AU2002328918B2 (en) 2008-09-04
RU2291866C2 (ru) 2007-01-20
JP4454310B2 (ja) 2010-04-21
WO2003035633A1 (en) 2003-05-01
HUP0401989A2 (hu) 2005-01-28
KR100896542B1 (ko) 2009-05-07
EP1436277A1 (en) 2004-07-14
US20040266859A1 (en) 2004-12-30
KR20040045023A (ko) 2004-05-31
MXPA04003519A (es) 2004-07-23
ITMI20012186A1 (it) 2003-04-19
BR0213360A (pt) 2004-10-26
ES2376162T3 (es) 2012-03-09
CN1271061C (zh) 2006-08-23
BR0213360B1 (pt) 2014-04-15
HK1069170A1 (en) 2005-05-13

Similar Documents

Publication Publication Date Title
NO20034660D0 (no) Spiropyrazolforbindelser
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
DE602005020666D1 (en) Mif-hemmer
MXPA04006636A (es) Compuestos de geranilo.
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина
HK1088325A1 (en) Process for the preparation of baccatin III derivatives
IL185920A0 (en) A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate
DK1347984T3 (da) Fremgangsmåde til fremstilling af taxanderivater
HK1069170A1 (en) A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate
CY1105699T1 (el) Νεες φαρμακευτικες ενωσεις με αλφα2υποδοχεα δραστηριοτητας
EA200400876A1 (ru) Способ получения производных толуола
DK1339703T3 (da) Fremgangsmåde til fremstilling af paclitaxel
ATE275551T1 (de) Halogenpyrimidine
NO20020328L (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
ATE282611T1 (de) Stolonoxide
CY1115144T1 (el) Παραγωγα του uk-2a
DK1444244T3 (da) Fremgangsmåde til fremstilling af desclarithromycin, samt mellemprodukter